TCL Archive In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts” March 26, 1976
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief. January 18, 2002
TCL Archive Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years. October 31, 2008